A dialogue between the hypoxia-inducible factor and the tumor microenvironment.
about
Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesTargeting the tumor vasculature to enhance T cell activityHypoxia-inducible aryl hydrocarbon receptor nuclear translocator (ARNT) (HIF-1β): is it a rare exception?Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor MicroenvironmentHypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytesIn vivo pH in metabolic-defective Ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH.Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasisTargeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.On the Pro-Metastatic Stress Response to Cancer Therapies: Evidence for a Positive Co-Operation between TIMP-1, HIF-1α, and miR-210CXCR4 as biomarker for radioresistant cancer stem cells.Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.RNA Activation of the Vascular Endothelial Growth Factor Gene (VEGF) Promoter by Double-Stranded RNA and Hypoxia: Role of Noncoding VEGF Promoter TranscriptsTumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets.Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer.Immature myeloid cells are critical for enhancing bone fracture healing through angiogenic cascade.Acidic preparations of lysed platelets upregulate proliferative pathways in osteoblast-like cells as demonstrated by genome-wide microarray analysis.Partial Oxygen Pressure Affects the Expression of Prognostic Biomarkers HIF-1 Alpha, Ki67, and CK20 in the Microenvironment of Colorectal Cancer Tissue.Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness.REDD1 expression in placenta during human gestation.BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation.Comparison of specific expression profile in two in vitro hypoxia models.Associations of high-altitude polycythemia with polymorphisms in PIK3CD and COL4A3 in Tibetan populationsChronic Hypoxia Emerging as One of the Driving Forces behind Gene Expression and Prognosis of Hepatocellular CarcinomaRenin-angiotensin inhibitors reprogram tumor immune microenvironment: A comprehensive view of the influences on anti-tumor immunity
P2860
Q26991991-EB4C86AA-1C19-4C54-9BBA-63332484EF47Q27026329-FCFC37DE-364A-44A3-9BB5-04C1B27C3225Q27027475-468C5FE5-240D-4288-9C32-EC79A5B7F7C7Q28069459-3BCCFF64-AC83-4812-88C9-330049C07118Q28579213-59959883-D261-4511-B059-30B1BF46B206Q33870048-5231A4A4-2D7B-4ADF-9FD0-236D40123E2AQ34031959-6FDAB801-BB07-4A05-BD5B-057BA21670A7Q34097528-8539C17E-D46F-4D1D-855A-87A84F0D16A7Q36497267-1ED596B8-D459-4AE0-ACFE-B48546DABFACQ36620552-29482222-2EB3-46C1-8D32-61AB07033D90Q36866279-0E016C7A-A016-4CEC-A2D1-89450743414FQ37800793-BC39459B-08E7-44FD-8026-372EFAFCCCEEQ37830361-F8C86FAD-F5E9-43EE-9812-16860AF80629Q38027146-9165B7AB-1B11-40BD-8F30-ACC05DE493E4Q38197709-209B921E-5084-405F-9FD7-192DC752F1A2Q38704678-D8A5821B-C499-4E0A-B05A-49AC9D161930Q38786357-61CC9C46-7819-4B31-B386-DAD145AE3E83Q38998166-C6878E53-E27F-4BD6-A519-C0E7046D891BQ39037708-E4B2D1C6-7B43-47A2-9577-0FBADE2B755FQ39056231-459E0F00-8998-42EA-896A-DD95FF84F9FBQ39355031-865EEAD0-A81B-4598-84FD-D9BD2BB90D5CQ39510354-D8110675-66FC-403F-BFA4-A5B9A84E27DDQ41860766-D5277508-58CC-44DC-92F9-22727B28ABFEQ50034271-4FDB37B9-4479-41D1-A3C6-62E7D602D398Q51790712-D159C333-E06B-4131-A076-395261BE09CCQ52882453-F4334F90-939A-4C5B-886E-70FA2E106ADCQ55002640-D1535081-5D3D-47D1-B1BB-D41693FDFB12Q57092190-06F95BDE-EB9A-4546-8117-BD39C6F9F131Q58689162-EE04FDED-B79C-427B-B4AC-EF153EF45DB5Q59125636-ABCF6A26-E7FD-4665-8EF4-C9F9DED3B510
P2860
A dialogue between the hypoxia-inducible factor and the tumor microenvironment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A dialogue between the hypoxia-inducible factor and the tumor microenvironment.
@en
A dialogue between the hypoxia-inducible factor and the tumor microenvironment.
@nl
type
label
A dialogue between the hypoxia-inducible factor and the tumor microenvironment.
@en
A dialogue between the hypoxia-inducible factor and the tumor microenvironment.
@nl
prefLabel
A dialogue between the hypoxia-inducible factor and the tumor microenvironment.
@en
A dialogue between the hypoxia-inducible factor and the tumor microenvironment.
@nl
P2093
P2860
P1433
P1476
A dialogue between the hypoxia-inducible factor and the tumor microenvironment.
@en
P2093
Frédéric Dayan
M Christiane Brahimi-Horn
Nathalie M Mazure
P2860
P2888
P356
10.1007/S12307-008-0006-3
P577
2008-03-19T00:00:00Z